Reverse DCF
What growth does the market imply for SYNGENE?
Working backwards from the current price to find the FCF growth assumption baked in.
reasonable
16.1% implied annual FCF growth
The market's growth assumption looks achievable — it is in line with or below what this company has historically delivered.
Current Price
₹437
Historical Growth
16.7%
FCF Yield
3.55%
Price / FCF
28.2x
Plain English
To justify today's price of $437.10, SYNGENE.NS needs to grow its free cash flow at 16.1% per year for the next 10 years. That is 0.6% slower than its historical growth rate of 16.7%. This looks achievable — the market is not pricing in heroic assumptions. There may be genuine upside if the company executes.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Half implied | 8.0% | ₹242 | -44.7% |
| GDP rate | 10.0% | ₹280 | -36.0% |
| Implied | 16.1% | ₹440 | +0.6% |
| Historical | 16.7% | ₹460 | +5.3% |
At Historical Growth Rate
It would take 10 years for SYNGENE to organically grow into today's price assuming its historical FCF growth of 16.7%.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, Monte Carlo, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.